Chemotherapy Safety Standards in the Developing World: is G CSF the Only Option?
Journal Title: Biomedical Journal of Scientific & Technical Research (BJSTR) - Year 2017, Vol 1, Issue 1
Abstract
The developing world poses a new set of challenges for the ever more demanding field of oncology. Not only that one has to cope with the concept of new treatments, there are different patient expectations and difficulties with compromised and limited services in remote areas. Issues such as language barriers, paucity of trained staff and lack of health educators are common and need to be kept in check before confirming any treatment options. In this environment there are tough challenges like suitability for appropriate chemo regimen particularly in the palliative setting, safety of treatment delivery and monitoring. Furthermore there is little if any expertise available in remote areas that can cope with different treatment related toxicities. Combined with reluctance of people to travel considerable distances to reach medical facilities, problems are often overlooked and present at a stage too late for salvage. In this environment will it be safe to rely on measures such as G CSF only and a bigger question will this be enough? In accordance with the available evidence, hematological toxicity from chemotherapy, neutropenic complications in particular are the most fearsome. This is counted to be the most common cause for serious events in chemotherapy related treatments as well as commonest reasons for hospital admissions as well as delay in subsequent chemotherapy cycles that can prove to be detrimental in patients overall outcome [1]. In line with the proposed guidelines NCCN as well as EORTC guidance updated in 2011, there are recommendations for prophylactic as well as therapeutic usage of G CSF. This is based on percentage risk of FN (febrile neutropenia) associated with a particular regimen. This has been classified as High risk based on the 20% or more incidence of FN with a known chemo regimen or Intermediate i.e. between 10-20% risks of FN. In addition there are identifiable patient related factors such as age and co morbidities that have also been suggested as important in decision algorithms for the use of G CSF [2-5]. Risk assessment dictates the approach to therapy, including the need for inpatient admission, IV antibiotics, and prolonged hospitalization Low-risk patients are defined as those who are expected to be neutropenic (absolute neutrophil count [ANC] <500 cells/microL) for ≤7 days and those with no comorbidities or evidence of significant hepatic or renal dysfunction. Most patients receiving chemotherapy for solid tumors are considered to be low-risk for complications requiring hospitalization or prolonging hospitalization.
Authors and Affiliations
Arif Adnan Shaukat, Touqeer Ahmed Siddiqui
Keywords
Related Articles
- EP ID EP567592
- DOI 10.26717/BJSTR.2017.01.000155
- Views 138
- Downloads 0
Non-Spanning Syringe Distractor: An Alternative Technique for Fracture Distal End Radius Fixation for Rural Areas of Developing Countries with Limited Resources
Introduction: Operative fixation of distal radius fractures is one of the most commonly performed orthopedic procedures. Though external fixator is a well-established method of treatment for unstable and comminuted fract...
Investigation of Biosynthesized Silver Nano Particles Interaction From Halymenia Porphyroides With The E7 Protein Using Bioinformatics Tool
Silver nano particles have known to possess anticancer properties in the early stages of virus proliferation. In the present study biosynthesis of silver nano particles from marine red alga Halymenia porphyroides was syn...
Detection of Eye Movements of ALS Patients
ALS is one of the most common neuromuscular diseases worldwide, and people of all races and ethnic backgrounds are affected. ALS most commonly strikes people between 40 and 60 years of age, but younger and older people a...
Interpretation of Non-Genetic Oral and Maxillofacial Osteogenic Conditions in the Basis of New Findings in the Field of Osteoblastogenesis and Osteoclastogenesis
Aims: The paper reorganized new findings in the field of osteoblastogenesis and osteoclastogenesis for clinicians to identify systemic and local risks of oral and maxillofacial osteogenic conditions (OMOCs) that are not...
Reactive Oxygen Species Over Production and Superoxide Dismutase Exhaustion Promoting the Intervertebral Disc Degeneration
Background: Oxidative overstress is realized as one of the most prevalent causes of Intervertebral Disc Degeneration (IVDD) by restraining the metabolism and damaging the cell matrix, but the specific process i...